Aquaflor

Manufacturer
Merck Sharp & Dohme Corp.
Effective date
2025-09-25
Label type
VFD TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL
Version
10
Source
full-release
Hydrated at
2026-06-01 02:45:02

Label at a glance#

ProductAquaflor Type A Medicated Article
Active ingredientFLORFENICOL
Label structure8 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Type A Medicated Article
For Use in Freshwater-reared Finfish Feeds Only

Do Not Feed Undiluted

CAUTION

SPL UNCLASSIFIED SECTION

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Active Drug Ingredient

SPL UNCLASSIFIED SECTION

Florfenicol 500 g per kg (227.27 g per lb)

Inert ingredients

SPL UNCLASSIFIED SECTION

Lactose and Povidone.

Description

DESCRIPTION SECTION

Each kg of Aquaflor® (florfenicol) contains 500 g (1.1 lb) of florfenicol in a palatable base.

Indications

INDICATIONS & USAGE SECTION

Fish SpeciesIndicationFlorfenicol
(mg/kg body
weight/day)
Florfenicol
(grams/ton)
Caution: Not for use in animals intended for breeding purposes. The effects of florfenicol on reproductive performance have not been determined. Toxicity studies in dogs, rats, and mice have associated the use of florfenicol with testicular degeneration and atrophy. For catfish, a dose related decrease in hematopoietic/lymphopoietic tissue may occur. The time required for the hematopoietic/lymphopoietic tissues to regenerate was not evaluated.
Freshwater-reared salmonidsFor the control of mortality due to furunculosis associated with Aeromonas salmonicida.10 - 15182-2,724
For the control of mortality due to coldwater disease associated with Flavobacterium psychrophilum.
Freshwater-reared finfishFor the control of mortality due to columnaris
disease associated with Flavobacterium columnare.
10 - 15182-2,724
CatfishFor the control of mortality due to enteric septicemia of catfish associated with Edwardsiella ictaluri.10 - 15182-2,724
Freshwater-reared warmwater finfish For the control of mortality due to streptococcal septicemia associated with Streptococcus iniae.15273- 2,724

RESIDUE WARNING

RESIDUE WARNING SECTION

Feeds containing Aquaflor® (florfenicol) must be withdrawn 15 days prior to slaughter.

IMPORTANT

SAFE HANDLING WARNING SECTION

This product has been evaluated in salmonid and catfish feeds and should be used in feeds nutritionally similar to these evaluated feeds. Refer to the Freedom of Information Summary for details. Must be thoroughly mixed in feeds or surface-coated (top-coated) onto the feeds before use.

Mixing Instructions

INFORMATION FOR OWNERS/CAREGIVERS SECTION

SPL UNCLASSIFIED SECTION

For incorporation into feed pellets: For making Aquaflor® (florfenicol) Type C Medicated Feed:

  • Aquaflor® (florfenicol) is added to other feed ingredients in the mixer prior to extrusion,
  • the ingredients are mixed thoroughly to insure homogeneity,
  • the mixture is steam pelleted or extruded and pellets are dried,
  • medicated feed pellets are mixed/coated with a predetermined amount of fish or vegetable oil, and
  • at the completion of mixing, the product is transferred to a storage tank for packaging or transport.
SPL UNCLASSIFIED SECTION

For surface-coating (top-coating) onto feed pellets: There are two methods for making Aquaflor® (florfenicol) Type C Medicated Feed by top-coating.

Method 1:

  • add a known quantity of fish feed into a mixer,
  • weigh out Aquaflor® (florfenicol),
  • mix Aquaflor® with feed pellets,
  • medicated feed pellets are mixed/coated with a predetermined amount of fish or vegetable oil, and
  • at the completion of mixing, the product is transferred to a storage tank for packaging or transport.

Method 2:

  • weigh out fish oil or vegetable oil into a bucket,
  • weigh out Aquaflor® (florfenicol) and mix thoroughly with the oil in the bucket,
  • add a known quantity of fish feed into a mixer,
  • add the Aquaflor® (florfenicol) and oil mixture to the feed in the mixer, slowly, while the mixer is running at low speed,
  • at the completion of mixing, the product is transferred to a storage tank for packaging or transport.
SPL UNCLASSIFIED SECTION
Example of Aquaflor® (florfenicol) Inclusion Rates for Preparation of Type C Medicated Feed
Feeding RateFlorfenicol Concentration in FeedAmount of Aquaflor® (florfenicol) per Ton of FeedBiomass of Fish Medicated per Ton of Feed per 10-day Treatment Period
% BiomassGrams/tonlbslbs
Dose
10 mg/kg
Dose
15 mg/kg
Dose
10 mg/kg
Dose
15 mg/kg
0.51,8162,72481240,000
19081,3624620,000
24546812310,000
33004501.321.986,666
51822730.81.24,000

Feeding Directions

SPL UNCLASSIFIED SECTION

Feed as the sole ration for 10 consecutive days. Aquaflor® (florfenicol) medicated feed should only be administered once disease has been appropriately diagnosed. Feeding fish at a percent of biomass and corresponding florfenicol concentration included in the table above will deliver the appropriate florfenicol dose.

Caution

GUARANTEED ANALYSIS OF FEED SECTION

Feed containing Aquaflor® (florfenicol) shall not be fed to finfish for more than 10 days. Following administration, fish should be re-evaluated by a licensed veterinarian before initiating a further course of therapy. The expiration date for VFD for Aquaflor® (florfenicol) must not exceed 6 months from the date of issuance. VFD for Aquaflor® (florfenicol) shall not be refilled.

Sunburn, skin lesions, and skin sloughing have been reported in salmonids treated with florfenicol. Not all adverse drug events are reported to FDA CVM. It is not always possible to reliably estimate the adverse event incidence or to establish a causal relationship to product exposure using this data alone.

Before using this drug for the first time, you must inform the appropriate National Pollutant Discharge Elimination System (NPDES) permitting authority of your intentions and of the following information. Acute and chronic water quality benchmarks for the protection of freshwater aquatic life have been derived by FDA for florfenicol following EPA guidance for calculating Tier II water quality criteria for the Great Lakes System (40 CFR 132, App. A). The acute benchmark value (Secondary Maximum Concentration) is 20.6 mg/L (equivalent to one-half of the Secondary Acute Value). The chronic benchmark value (Secondary Continuous Concentration) is 0.23 mg/L (equivalent to the Final Plant Value). The NPDES authority may require an NPDES permit before you can discharge Aquaflor®. The water quality benchmark concentrations are not discharge limits, but may be used by the NPDES authority to derive such limits for the permit. Additional environmental information on Aquaflor® and the benchmark values are available in an environmental assessment posted at animaldrugsatfda.fda.gov/adafda/views/#/environmentalAssessments

WARNING

WARNINGS SECTION

Avoid inhalation, oral exposure, and direct contact with skin or eyes. Operators mixing and handling Aquaflor® (florfenicol) should use protective clothing, gloves, goggles and NIOSH-approved dust mask. Wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse thoroughly with water. If irritation persists, seek medical attention. Not for human consumption. Keep out of reach of children. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For more information or to report adverse effects, call 1-800-224-5318. For customer service, call 1-800-521-5767. For a copy of SDS sheet, call 1-800-770-8878.

STORAGE CONDITIONS

STORAGE AND HANDLING SECTION

Store at temperatures up to 25°C with excursions permitted to 40°C.

SPL UNCLASSIFIED SECTION

Approved by FDA under NADA # 141-246
Copyright © 2013 - 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Formulated in Austria.
Rev. 6/2022

LOT:
EXP:

LogoLogo

FigureFigure

354296 R4

PRINCIPAL DISPLAY PANEL - 2 kg Pouch Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

2 kg (4.4 lb)

Aquaflor®
(Florfenicol)
Type A Medicated Article
For Use in Freshwater-reared Finfish Feeds Only

Do Not Feed Undiluted

CAUTION: Federal law restricts medicated feed containing this veterinary feed directive
(VFD) drug to use by or on the order of a licensed veterinarian.

Active Drug Ingredient: Florfenicol 500 g per kg (227.27 g per lb)

Description: Each kg of Aquaflor® (florfenicol) contains 500 g (1.1 lb)
of florfenicol in a palatable base.

Approved by FDA under NADA # 141-246

Copyright © 2013 - 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Florfenicol (active ingred.) made in China. Formulated in Austria.

Rev. 6/2022

MERCK
Animal Health

368029 R4

PRINCIPAL DISPLAY PANEL - 2 kg Pouch Label
PRINCIPAL DISPLAY PANEL - 2 kg Pouch Label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0061-1355-01AquaflorType A Medicated Article2 kg in 1 POUCHPOWDER210

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
florfenicolACTIVE INGREDIENT9J97307Y1H5
florfenicolACTIVE MOIETY9J97307Y1H5
Lactose MonohydrateINACTIVE INGREDIENTEWQ57Q8I5X5
PovidonesINACTIVE INGREDIENTFZ989GH94E5

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0061-13550061-1355-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
FLORFENICOL9J97307Y1HACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 68 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PovidonesPOVIDONEFZ989GH94ESUSPENSION/ DROPS / OPHTHALMIC0.6 %w/vExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ETABLET / SUBLINGUAL6 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS174 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, FOR SUSPENSION / ORAL2794 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XPELLET / ORAL640 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS214 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94EPOWDER, FOR SUSPENSION / ORAL35 mg/5mlExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ECAPSULE, COATED PELLETS / ORAL10.03 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, FILM COATED, EXTENDED RELEASE / ORAL520 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ESUSPENSION / OPHTHALMIC1.8 %w/vExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ESUSPENSION / ORAL20 mg/5mlExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ETABLET, COATED / ORAL49.2 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XPOWDER / RESPIRATORY (INHALATION)25 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ETABLET, DELAYED RELEASE / ORAL53 mgExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ETABLET, ORALLY DISINTEGRATING / ORAL15.03 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XGRANULE, FOR SOLUTION / ORAL1691.8 mg/120mlExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ETABLET / ORAL216 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XTABLET / SUBLINGUAL505 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ECAPSULE, DELAYED RELEASE / ORALNAExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94EINJECTION / INTRAMUSCULAR0.2 %w/vExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XCAPSULE, DELAYED RELEASE / ORAL2087 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ETROCHE / ORAL30 mgExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94EIMPLANT / SUBCUTANEOUS6 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION / INTRAVENOUS900 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XCAPSULE, EXTENDED RELEASE / ORAL5364 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XPOWDER, FOR SUSPENSION / ORALNAExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ECAPSULE, DELAYED RELEASE PELLETS / ORAL32 mgExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ESOLUTION / ORAL3000 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, FILM COATED / ORAL968 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ESOLUTION / OPHTHALMIC1.8 %w/vExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR214 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XCAPSULE, COATED / ORAL300 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION / INTRAMUSCULAR150 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ETABLET, EXTENDED RELEASE / ORAL101 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS690 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS107 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ECAPSULE / ORAL300 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XTABLET / BUCCAL43 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XINSERT / VAGINAL2282 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94EGRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL350 mgExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ESUSPENSION / AURICULAR (OTIC)NAExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ETABLET, FILM COATED / ORAL240 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, EXTENDED RELEASE / ORAL2575 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ECAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ETABLET, FILM COATED, EXTENDED RELEASE / ORAL17 mgExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ETABLET, CHEWABLE / ORAL48 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY47.5 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS9.5 %w/vExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XTABLET / ORAL4384 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, DELAYED RELEASE / ORAL2313 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS750 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, ORALLY DISINTEGRATING / ORAL366 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XCREAM / VAGINAL586 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ETABLET, FOR SUSPENSION / ORAL2 mgExact identifier — unii candidate
30 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94EDROPS / ORALNAExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XCAPSULE / ORAL3990 mgExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, COATED / ORAL1301 mgExact identifier — unii candidate
38 equally ranked IID candidates
PovidonesPOVIDONEFZ989GH94ECAPSULE, EXTENDED RELEASE / ORAL56 mgExact identifier — unii candidate
30 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XGRANULE, FOR SUSPENSION / ORALNAExact identifier — unii candidate
38 equally ranked IID candidates
Lactose MonohydrateLACTOSE MONOHYDRATEEWQ57Q8I5XGRANULE / ORAL8946 mgExact identifier — unii candidate
38 equally ranked IID candidates

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.